Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context

Summary: Background: The SECURE trial (NCT02596126) demonstrated the efficacy of the cardiovascular polypill (“CV-Polypill”–acetyl salicylic acid, atorvastatin and ramipril) in reducing the risk of recurrent major cardiovascular events compared with standard care when initiated within six months of...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Thomas Gaziano, José María Castellano, Amy Dymond, Alissa Looby, Stuart Mealing, Ruth Owen, Stuart Pocock, José Ramón González-Juanatey, Alberto Cordero, Antonio Fernández-Ortiz, Aleš Linhart, François Schiele, Wolfram Doehner, Luisa Ojeda Fernández, Valentín Fuster
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2025-08-01
Σειρά:	The Lancet Regional Health. Europe
Θέματα:	Cost-effectiveness analysis Cardiovascular prevention CV-Polypill
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2666776225001401
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!